Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in Psoriasis. (Q52958415)
Jump to navigation
Jump to search
scientific article published in April 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in Psoriasis. |
scientific article published in April 2002 |
Statements
Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in Psoriasis. (English)
Hans-Dieter Volk
Markus Friedrich
Wolf-Dietrich Döcke
Anja Klein
Sandra Philipp
Wolfram Sterry
Khusru Asadullah
1 April 2002
118
4
672-677